A full-length cDNA clone for human thyroid peroxidase (TPO) In conclusion, we expressed enzymaticaliy active human TPO in nonthyroidal eukaryotic cells. Our data prove that functionally active TPO is a major component of the thyroid microsomal antigen.
Introduction
Hashimoto's thyroiditis is the most common autoimmune endocrinopathy, affecting, at least subclinically, up to 15% of the adult female population (1, 2) . Antibodies against a number of thyroid antigens are present in the sera of these patients, including thyroglobulin and the thyroid microsomal antigen (3, 4) . Other antigens of lesser or uncertain importance include the second colloid antigen (3) , tubulin (5) , DNA (6) , and au-toimmune thyroid disease-related antigen I (7) . Antibodies against the microsomal antigen, which is expressed on the cell surface (8, 9) , are believed to be of greater importance than those against thyroglobulin in the pathogenesis ofHashimoto's thyroiditis. This is because antimicrosomal antibodies (anti-MSA)' are more closely associated with the active phase ofthe disease (1, 10 , I 1) and are complement fixing (8) . These antibodies are, therefore, likely to initiate thyroid cellular damage.
A major recent discovery regarding Hashimoto's thyroiditis is that the previously ill-defined microsomal antigen is, at least in part, thyroid peroxidase (TPO), the primary enzyme involved in thyroid hormone synthesis. This conclusion was based on immunologic evidence (12) (13) (14) (15) and subsequently confirmed by the molecular cloning of the cDNA for these proteins (16) (17) (18) (19) and the discovery that their derived amino acid sequences are the same (18, 20) .
Until the present time, a suitable preparation of recombinant TPO has not been available for studies on the presumed abnormalities in immune regulation in Hashimoto's thyroiditis or for the demonstration of the specific B and T cell epitopes involved in this disease. In this respect, understanding of the molecular mechanisms involved in the pathogenesis of Hashimoto's thyroiditis lags far behind that of myasthenia gravis, a disease for which pure antigen (the acetylcholine receptor) has been obtained and epitopes already defined (21, 22) . Human TPO immunopurified by MAbs has been available but is of limited value because of (a) inadequate supplies of human thyroid tissue; (b) the difficulties in purification of this membrane-bound antigen; and (c) contamination with other thyroid autoantigens such as thyroglobulin, which is highly abundant. Fragments of human TPO have been generated as recombinant bacterial fusion proteins (18) . These, too, have been of limited value because (a) no combination of fragments has been found that react with all Hashimoto's sera; (b) the conformation ofthe fusion protein may differ from that of the native protein; and (c) the bacterial products may be toxic when added to immune cells in culture.
To obtain full-length human TPO free of other potential thyroid antigens for studying the pathogenesis of Hashimoto's thyroiditis, we attempted the expression of recombinant human TPO in nonthyroidal eukaryotic cells. Like native human TPO, this recombinant TPO is enzymatically active, is expressed on the cell surface, and is not a fusion protein. We demonstrate further that this protein is recognized in a specific manner by sera from patients with Hashimoto's thyroiditis that contain anti-MSA.
Methods
Construction of a human Graves' thyroid cDNA library. A thyroid cDNA library was constructed to maximize the inclusion of full-length cDNA in the coding orientation. Hyperplastic thyroid tissue was obtained from a patient undergoing thyroidectomy for Graves' disease. mRNA was isolated according to the method of Han et al. (23) . Double-stranded cDNA was synthesized from 15 Mg mRNA as described by Gubler and Hoffman (24) . Not I and Xba I linker-primers/adaptors were incorporated into the cDNA to create those restriction sites at the 5' and 3' ends, respectively, of the cDNA (23) . The cDNA was size selected (> 1 kb) by agarose gel (Seaplaque; FMC, Rockland, ME) electrophoresis, digested with Not I and Xba I, ligated into Not I-and Xba I-cut bacteriophage lambda-Zap using T4 DNA ligase, and packaged (Giga-Pak Gold; Stratagene, San Diego, CA). The resulting phage library contained a total of 2 X 104 recombinant clones before amplification.
Screeningforfull-length human TPO cDNA. The amplified cDNA library was plated at a density of 4 X 104 plaque-forming units per 1 50-mm-diam dish and probed using the insert from a partial human TPO cDNA clone (clone 19, reference 17). Two positive bacteriophage clones were isolated. A Bluescript phagemid containing the human TPO cDNA insert was generated from one of these clones using the helper phage R408, according to the Stratagene protocol. The resulting recombinant Bluescript plasmid (pHTPO-BS) contained bases 5-3,060 of human TPO cDNA, including the start of translation and the poly-A tail. DNA sequence was determined from this double- stranded plasmid using the Sequenase kit and protocol (United States Biochemical Corp., Cleveland, OH). Sequence within the cDNA was confirmed to be identical to human TPO cDNA at the 5' and 3' ends and in the regions adjacent to 10 oligonucleotide primers distributed throughout the cDNA (17) .
Construction of pHTPO-ECE. The mammalian cell expression vector pECE (25) NaCl; TBS), then for 30-60 min at room temperature in TBS containing 0.5% Tween 20 (Sigma Chemical Co.). After three further rinses with TBS-Tween the blots were probed as described by Young and Davis (32) using a 1:250 dilution of a mouse MAb against the thyroid microsomal antigen (33), followed by a 1:250 dilution of horseradish peroxidase-conjugated goat anti-mouse IgG antibody (Sigma Chemical Co.). In later experiments CHO-HTPO12b (see Re- sults) cell extracts were probed using a panel ofpolyclonal Hashimoto's thyroiditis sera, kindly provided by Dr. S. M. McLachlan (University ofWales, Cardiff). Anti-MSA titers had previously been determined by ELISA in the presence of excess thyroglobulin (11) . Multiple Hashimoto's thyroiditis sera (diluted 1:400 in TBS-Tween unless described otherwise in the text) were applied to a single filter overnight at 4°C using a Miniblotter 45 manifold (Immunetics, Cambridge, MA).
Membranes were then processed as described above, except that alkaline phosphatase-conjugated goat anti-human IgG, Fc fragment-specific (Cappel Laboratories, Cochranville, PA), was used as the second antibody with nitroblue tetrazolium (0.3 mg/ml) and 5-bromo-4-chloro-3-indolyl-phosphate (0.15 mg/ml) in 100 mM Tris, pH 9.5, 100 mM NaCl, and 5 mM MgC12.
FACS analysis. CHO-HTPO12b cells were processed as described by Ellis et al. (25) . In brief, cells from a 100-mm-diam dish were detached by mild trypsinization, and the cells rinsed and pelleted (5 min at 100 g, 4°C) in Ham's F-12 medium and 10% FCS (see above). The cells were resuspended in 0.2 ml of PBS, 10 mM Hepes, pH 7.4, 0.05% Na azide (buffer A). Serum to be tested (2 Ai) was added for 30 min at 4°C, followed by two rinses in buffer A with 2% FCS and resuspension in 0.2 ml of the same solution. 25 Al of goat anti-human IgG, Fc specific, affinity purified, R-phycoerythrin labeled (Caltag, South San Francisco, CA), was added for another 30 min at 4°C. After three washes in buffer A the cells were analyzed on a FACS.
Assay ofhuman TPO enzymatic activity. Human TPO activity was assayed after extraction from cell microsomes with trypsin and deoxycholate as previously described (34) . In later experiments a more rapid method was used. Cells were suspended with a rubber scraper in 1.5 ml calcium-magnesium-free PBS and protein was determined on a 5-Ml aliquot. The cells were then pelleted in a microcentrifuge for 2 min. Cold 0.1 % deoxycholate (0.2 ml/mg cellular protein) was added for 10 min. The extract was microcentrifuged for 5 min and the supernatant removed for assay. One guaiacol unit is defined as a AA470 of 1.0/min, which is equivalent to 150 nmol guaiacol oxidized/min (35). One unit of iodide peroxidase is defined as a AA353 of 1.0/min, which corresponds to 43 nmol I-formed/min (36) .
Primary culture of human Graves' disease thyroid cells. Human Graves' disease thyroid tissue was dispersed and the cells were cultured as previously described (37 
Results
Because multiple screenings of our previously constructed human thyroid cDNA library in lambda gtl 1 (17) only yielded fragments ofTPO cDNA, we constructed a new thyroid cDNA library in lambda-Zap, as described in Methods. The plasmid pHTPO-BS containing full-length human TPO cDNA was obtained from this library. pHTPO-ECE was constructed from pHTPO-BS and the mammalian expression vector pECE (25) according to the strategy shown in Fig. 1 , and was used for subsequent cell transfections.
CHO cells were cotransfected with pHTPO-ECE and pSV2-neo, and 12 clones were tested for the presence of TPO mRNA by Northern blot analysis. Four ofthese clones, as well as one of four control (pSV2-neo alone) clones, are shown in Fig. 2 A, and reveal a 3.3-kb mRNA band in the pHTPO-ECE-transfected clones. The size ofthe human TPO mRNA in the transfected CHO cells is slightly larger than that in the Graves' thyroid cells (3.1 kb), presumably because of the additional SV40 poly-A coding region at the 3' end of human TPO cDNA in the pHTPO-ECE plasmid (see Fig. 1 ).
Western blot analysis (under reducing conditions) of proteins extracted from TPO-transfected CHO cells using a mouse monoclonal anti-human thyroid microsomal antibody (33) revealed an immunoreactive protein of 105-110 kD, as expected for human TPO (12, 38) (Fig. 2 B) .
Strong TPO enzymatic activity was evident in clone CHO-HTPO 12 and in subclones CHO-HTPO1 2b and CHO-HTPO 1 2g, obtained by limiting dilution (Table I) . Less enzymatic activity was detected in the other clones (data not shown). TPO activity in the CHO-HTPO1 2 clones was approximately the same as TPO activity in TSH-stimulated Graves' thyroid cells in monolayer culture (Table I) .
To determine whether, as with native TPO in thyroid cells, the recombinant human TPO was expressed on the surface of the CHO cells transfected with this gene, CHO-HTPO 1 2b cells were subjected to FACS analysis (Fig. 3) . Incubation of these cells with high-titer anti-MSA Hashimoto's serum (ELISA value of 1.772; normal < 0.2) (11) yielded approximately 100-fold greater fluorescence than when these cells were incubated with control serum (Fig. 3) . Similar results were obtained with three different Hashimoto's sera (data not shown). The size of both the control and Hashimoto's serum-incubated cells was the same (Fig. 3, E and F) , excluding the possibility that differences in cell size were, in part, responsible for the differences in signal.
A series of Western blot studies were then performed with protein from CHO-HTPO12b cells using a panel of Hashimoto's sera with known anti-MSA levels as determined by ELISA (11) . Under nonreducing conditions, all 29 Hashimoto's sera tested, unlike three normal sera, reacted with a major, broad protein band of -200 kD, as well as with a fainter doublet of 110 kD (Fig. 4) 17) , from a control cell line cotransfected with pECE and pSV2-neo, and from another control cell line transfected with pSV2-neo alone, were subjected to SDS-PAGE under reducing conditions. The proteins were electrotransferred to nitrocellulose membranes and then probed, as described in Methods, with a mouse MAb against the thyroid microsomal antigen (33).
moto's sera tested, but not 6 control sera, reacted with these bands. The interexperimental variability in the intensity of these bands, however, as well as methodological limitations in analyzing many samples simultaneously, precluded comparison of results of all samples tested. Nevertheless, it is apparent that within a single large experiment (Fig. 4) (Fig. 5, lane 6) is the same serum used in Fig. 4 , lane 24 . This band represents a wild-type CHO protein, and not TPO (presented below). The nonspecific CHO proteins bound by some of the sera tested are more evident in Fig. 5 than in Fig. 4 because a more intense colorimetric development led to a higher background.
The specificity of the 200-and 10-kD bands discussed above was demonstrated in two separate experiments using wild-type, non-TPO-transfected CHO cells (Fig. 6) Fig. 4 Methods. (A) Cells exposed to phycoerythrin (PE)-labeled second antibody alone, without prior j200 exposure to human serum. (B) >robobiilt. 5 Cells ., reducing) conditions. Nonspecific CHO cell-reactive proteins appear stronger in Fig. 6 because the colorimetric reaction was continued for a longer period of time to emphasize the lack of specific signals in these control, non-TPO-containing cells.
To assess the sensitivity of detection of the specific signal, Western blot analyses were performed with serial dilutions of two Hashimoto's sera. The amount of TPO generated in CHO-HTPO12b cells is sufficient to be detected even when these Hashimoto's sera were diluted > 3,000-fold (Fig. 7) . Human TPO contains five potential glycosylation sites. We therefore examined whether carbohydrate moieties were important in the conformation of the epitope(s) in the human TPO antigen(s) recognized by Hashimoto's sera. Western blot analyses were performed on proteins extracted from CHO-HTPO I 2b cells precultured for 20 h in 0.5 5g/ml tunicamycin, an inhibitor of protein glycosylation. This length of time was chosen because it was the longest tolerated without evidence of significant toxicity (i.e., cell loss). Tunicamycin treatment had no apparent effect on antigen recognition (Fig. 8) Fig. 4 ).
used require extensive preadsorption of polyclonal antisera (7) and can yield false positive results. For example, a reported fusion protein originally described as reactive with 19 of 20 Hashimoto's sera (reference 18, clone C2) has, upon immunopurification with anti-,B-galactosidase MAbs, been found to react with fewer Hashimoto's sera in an ELISA assay (39) . In the present study, using eukaryotic recombinant TPO, we show that all 36 Hashimoto's sera, selected to represent a range of anti-MSA levels seen in this disease, were reactive.
Our data also shed light on previous observations that the microsomal antigen may appear as a doublet on PAGE and Western blot analysis (33, 40, 41) . It was unclear whether this doublet represented two separate proteins or the partial degradative product of a single protein. Kimura duced by subjecting the extracted human thyroid microsomal 107-kD protein major band to gel electrophoresis under nonreducing conditions (40) . Also, our finding ofa diminished 1 10-kD signal after reduction of the recombinant antigen is in accordance with other findings using the native microsomal antigen (44, 45) . These data taken together provide evidence that in its native state human TPO exists either as a multimer or in association with another membrane protein of similar size, and that epitope recognition by autoantibodies may be conformation dependent. Finally, studies with polyclonal antibodies using human thyroid microsomes suggest the existence of multiple TPO epitopes in Hashimoto's thyroiditis (46) . Our generation of an intact, functionally active, TPO protein that reacts with Hashimoto's antisera will hopefully facilitate studies to define the disease-specific epitope(s) recognized by autoantibodies.
